HB Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-15,000
Closed -$7.03M – 774
2023
Q2
$7.03M Buy
+15,000
New +$6.29M 0.11% 97

Other funds holding LLY

HB Wealth Management's LLY Position: Q2 2026 in Review

HB Wealth Management increased its Eli Lilly (LLY) stake by 2.3% in Q2 2026, buying an estimated $1.45M and bringing the position to 64,452 shares worth $77.3M. The position accounts for 0.43% of the portfolio, ranked #35.

HB Wealth Management first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • HB Wealth Management held 64,452 shares of Eli Lilly worth $77.3M as of Q2 2026.
  • HB Wealth Management bought 1,424 Eli Lilly shares in Q2 2026, an estimated $1.45M.
  • Eli Lilly made up 0.43% of HB Wealth Management's portfolio in Q2 2026, its #35 holding.
  • HB Wealth Management first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.